The Global Humira Biosimilar Market Is Estimated To Be Valued At US$ 772.1 Million In 2023 And Is Expected To Exhibit A CAGR Of 25.9%

Humira Biosimilar Market

Market Overview:

Humira(adalimumab) is a human monoclonal antibody used to treat various autoimmune diseases such as rheumatoid arthritis, Crohn's disease, ulcerative colitis and psoriasis. Biosimilar versions provide cost effective treatment options with comparable safety and efficacy.


Market key trends:
One of the key trends in the humira biosimilar market is the patent expiration of Humira's reference product. AbbVie's patent on Humira expired in major markets like Europe in October 2018 and will expire in the US in December 2023, allowing for biosimilar competition. This has led to several biosimilar approvals and launches by companies like Amgen, Sandoz and Boehringer Ingelheim. Increased biosimilar penetration is expected to substantially reduce treatment costs and expand patient access to biologic therapy for various chronic conditions.

Segment Analysis

The global Humira Biosimilar Market biosimilar market is dominated by the rhematoid arthritis sub-segment. Currently, Humira is approved for the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis and uveitis. The rheumatoid arthritis sub-segment holds the largest market share as rheumatoid arthritis is the most common chronic inflammatory condition affecting approximately 1% of the adult population globally. Humira has been approved for the treatment of moderate to severe active rheumatoid arthritis.

Key Takeaways

The global Humira biosimilar market is expected to witness high growth, exhibiting CAGR of 25.9% over the forecast period 2023 - 2030, due to increasing prevalence of immune-mediated inflammatory diseases globally.

Regional analysis

The US region currently dominates the global Humira biosimilar market with a share of over 60% in 2023. However, the Asia Pacific region is expected to emerge as the fastest growing market during the forecast period. Countries like China, India, South Korea and Japan are expected to offer lucrative opportunities for market players due to rising healthcare spending and increasing generic penetration in the region.

Key players

Key players operating in the Humira biosimilar market are Amgen Inc., Samsung Bioepis Co., Ltd., Sandoz International GmbH (Novartis AG), Mylan N.V., Boehringer Ingelheim International GmbH, Pfizer Inc., Fresenius Kabi AG, Coherus BioSciences, Inc., Biogen Inc., AbbVie Inc., Celltrion Inc., Amneal Pharmaceuticals, Inc., Lupin Pharmaceuticals, Inc., Merck & Co., Inc., Viatris Inc. Amgen Inc. generated the highest revenue from Humira biosimilars in 2023.

Comments

Post a Comment

Popular posts from this blog

Location-Based Services Market to Reach US$ 32,210 Million in 2022

Image
Location-Based Services Market Market Overview: The global Location-Based Services (LBS) Market is estimated to be valued at US$ 32,210 Million In 2022 and is expected to exhibit a CAGR of 18.7% over the forecast period from 2023 to 2030. Location-Based Services enable businesses and organizations to provide personalized services and target customers based on their real-time geographic location. These services offer benefits such as increased customer engagement, improved operational efficiency, and enhanced decision-making. The need for Location-Based Services is driven by the growing adoption of smartphones and the increasing demand for location-aware applications in various industries including retail, healthcare, transportation, and hospitality. Market Key Trends: One key trend in the Location-Based Services Market is the integration of LBS with Internet of Things (IoT) technology. The convergence of LBS and IoT allows businesses to track and monitor assets in real-time, enablin...
Read more

Precision Medicine Market to Reach US$ 73,946.2 Million In 2022: Coherent Market Insights

Image
Precision Medicine Market The global Precision Medicine Market is projected to reach a value of US$ 73,946.2 Million In 2022 , with a CAGR of 10.3% over the forecast period 2022-2030, according to a new report by Coherent Market Insights. Market Overview: Precision Medicine involves personalized treatment plans and therapies based on an individual's genetic makeup, lifestyle, and environment. It offers several advantages, such as improved treatment outcomes, minimized adverse effects, and targeted therapy for complex diseases. The need for Precision Medicine is increasing due to rising cases of chronic and genetic diseases, increasing healthcare expenditure, and advancements in genomics technology. Market Key Trends: One key trend in the Precision Medicine Market is the use of genomic sequencing. Genomic sequencing refers to the process of determining the complete DNA sequence of an individual. It plays a crucial role in identifying genetic variations and mutations that can be t...
Read more

The Evolution And Growth Of The Europe E-Bike Market: A Journey Towards Sustainable Mobility

Image
Europe E-Bike Market In recent years, the Europe E-bike Market has witnessed a remarkable transformation, reflecting the continent's commitment to sustainable and eco-friendly transportation solutions. Electric bikes, or e-bikes, have emerged as a popular choice for commuters and outdoor enthusiasts alike, bridging the gap between traditional bicycles and motorized vehicles. This paper explores the evolution of the Europe e-bike market, delving into its factors driving growth, market trends, regulatory landscape, environmental impact, and the challenges and opportunities it presents. The roots of e-bikes can be traced back to the late 19th century, but it was only in the last two decades that they gained significant traction in Europe. Factors such as increasing urbanization, traffic congestion, rising environmental awareness, and technological advancements in battery and electric motor technologies played a pivotal role in their popularity. E-bikes offered an efficient and sust...
Read more